Maintenance of Response to Risankizumab in Patients With Psoriatic Arthritis: A 4-Year Analysis of the KEEPsAKE 1 and 2 Trials. (2024). SKIN The Journal of Cutaneous Medicine, 8(6), s444. https://doi.org/10.25251/skin.8.supp.444